Dr. Amber M. D'Souza
Claim this profileSaint Jude Midwest Affiliate
Expert in Tumors
Expert in Cancer
37 reported clinical trials
83 drugs studied
About Amber M. D'Souza
Education:
- Earned an MD (Doctor of Medicine).
Experience:
- Serves as an Assistant Professor in Pediatric Hematology and Oncology at the University of Illinois College of Medicine Peoria, affiliated with St. Jude Midwest Affiliate in Children's Hospital of Illinois.
- Completed residency at Children's Hospital of Pittsburgh of UPMC in 2015.
- Finished a fellowship in pediatric hematology/oncology.
- Lead co-investigator in an AHRQ U18 Pediatric Quality Measurement Program grant.
- Conducted important research during the COVID-19 pandemic related to school reopening strategies.
Area of expertise
1Tumors
Global LeaderStage I
Stage II
Stage IV
2Cancer
Global LeaderStage I
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Amber M. D'Souza is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selinexor + Radiation
for Brain Cancer
This trial tests the safety and effectiveness of combining selinexor with radiation therapy in children and young adults with aggressive brain tumors. Selinexor is a drug that blocks a protein to stop cancer cells from growing. The study aims to find the best dose and see if this combination can shrink tumors.
Recruiting1 award Phase 1 & 21 criteria
More about Amber M. D'Souza
Clinical Trial Related7 years of experience running clinical trials · Led 37 trials as a Principal Investigator · 15 Active Clinical TrialsTreatments Amber M. D'Souza has experience with
- Cyclophosphamide
- Radiation Therapy
- Etoposide
- Doxorubicin Hydrochloride
- Carboplatin
- Nivolumab
Breakdown of trials Amber M. D'Souza has run
Tumors
Cancer
Brain Tumor
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amber M. D'Souza specialize in?
Amber M. D'Souza focuses on Tumors and Cancer. In particular, much of their work with Tumors has involved Stage I patients, or patients who are Stage II.
Is Amber M. D'Souza currently recruiting for clinical trials?
Yes, Amber M. D'Souza is currently recruiting for 13 clinical trials in Peoria Illinois. If you're interested in participating, you should apply.
Are there any treatments that Amber M. D'Souza has studied deeply?
Yes, Amber M. D'Souza has studied treatments such as Cyclophosphamide, Radiation Therapy, Etoposide.
What is the best way to schedule an appointment with Amber M. D'Souza?
Apply for one of the trials that Amber M. D'Souza is conducting.
What is the office address of Amber M. D'Souza?
The office of Amber M. D'Souza is located at: Saint Jude Midwest Affiliate, Peoria, Illinois 61637 United States. This is the address for their practice at the Saint Jude Midwest Affiliate.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.